Jim is a Managing Director of New York-based investment firm Altaris Capital Partners, LLC, where he leads the firm’s investments in the medical device and diagnostics sectors. Altaris is a minority shareholder in Minnetronix. Focused exclusively on the healthcare industry, Altaris invests in businesses that deliver value to the healthcare system by improving patient outcomes, reducing costs, increasing efficiency and aligning stakeholder incentives. Prior to joining Altaris, Jim was a member of the investment banking and equity capital markets groups at Merrill Lynch where he assisted clients in the execution of a number of mergers, acquisitions and corporate finance transactions across various industries. Jim received a B.A. in History from Princeton University.